
Research ArticleDynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
Keywords: شیمی درمانی مترونومیک; Metronomic chemotherapy; Sorafenib; Tegafur/uracil; Vascular response; AFP; alpha-fetoprotein; DCE-MRI; dynamic contrast-enhanced magnetic resonance imaging; HCC; hepatocellular carcinoma; IAUC; initial area under the gadolinium concentration-time curve;